Prosecution Insights
Last updated: October 02, 2026

Examiner: BANERJEE, KOYELI

Tech Center 1600 • Art Units: 1654 1658 1675 1699

This examiner grants 50% of resolved cases

Analysis

Koyeli Banerjee operates within Tech Center 1600 and Art Unit 1654. The examiner has 2 resolved cases, which result in an allowance rate of 50.0%. This rate provides a starting point for understanding the likelihood of success in this art unit. The interview lift is currently 0.0%, indicating that interviews have not yet shown a statistical impact on the 50.0% allowance rate. With only 2 cases resolved, these figures represent an early stage of data collection.

The median days to allowance for these applications is 1148. This pendency of 1148 days is the primary timeline metric available for Art Unit 1654 in this profile. Practitioners should note that the 0.0% interview lift and 50.0% allowance rate are derived from a very small sample of 2 cases. As the examiner resolves more applications in Tech Center 1600, these performance indicators may evolve. For now, the 1148 days median serves as the expected duration for reaching a resolution.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

50.0%
Allow Rate
-10.0% vs TC avg
24
Total Applications
+0.0%
Interview Lift
1148
Avg Prosecution Days
Based on 2 resolved cases, 2023–2026

Rejection Statute Breakdown

11.1%
§101 Eligibility
13.9%
§102 Novelty
41.0%
§103 Obviousness
18.8%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18735130 METHOD FOR PRODUCING PEPTIDE COMPOUND, PROTECTIVE GROUP-FORMING REAGENT, AND SUBSTITUTED BENZYL COMPOUND Non-Final OA FUJIFILM Corporation
18742659 RNA-Dependent RNA Polymerase Inhibitory Compounds, Uses in Managing Viral Infections, and Pharmaceutical Compositions Non-Final OA Emory University
18359793 Novel Peptide Carrier Compositions Non-Final OA The Regents of the University of Colorado, A Body Corporate
18728874 BONE TARGETED TREATMENT IN OSTEOGENESIS IMPERFECTA Non-Final OA PURDUE RESEARCH FOUNDATION
18814954 Reagents and methods for treating bacterial infection Non-Final OA University of Washington
18554285 PEPTIDE-SMALL INTERFERING RNA-HYALURONIC ACID NANOPARTICLES AND METHODS OF USE THEREOF Non-Final OA UNIVERSITY OF SOUTH FLORIDA
18574161 METHOD OF RECONSTITUTING LYOPHILIZED FORMULATION Non-Final OA AMGEN INC.
18251553 MATERIALS AND METHODS FOR PROTEIN PROCESSING Final Rejection AMGEN INC.
18695526 PEPTIDE HAVING ACTIVITY OF PREVENTING HAIR LOSS OR PROMOTING HAIR GROWTH AND USE THEREOF Non-Final OA CAREGEN CO., LTD.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month